Radezolid是一种噁唑烷酮类抗生素。它对衣原体，军团菌葡萄球菌，和Linezolid 耐药菌株有活性。

Radezolid is a novel oxazolidinone antibiotic agent.

Radezolid displays a greater potency than linezolid, independent of the bacteria tested, when concentrations are expressed on a weight (mg/L) basis. Radezolid shows an improved potency compared to that of linezolid when concentrations are expressed on a weight (mg/L) basis. Radezolid MICs are systematically equal to or lower (up to 3 log2 dilutions) compared to those of linezolid for all linezolid-susceptible strains, with an 8-fold difference for the linezolid-resistant strains. Radezolid and TR-700 perform well against 3-copy G2447T, G2576T, and G2576T/T2571C mutants [1][2].

869884-78-6

C22H23FN6O3

438.45

雷得唑来;RX-1741;Radezolid

DMSO:25 mg/mL (57.02 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years